| 688050 Stock | | | 90.61 1.90 2.05% |
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Eyebright Medical Technology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in nation.
At present, Eyebright Medical's
Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's
Net Working Capital is expected to grow to about 862.1
M, whereas
Net Invested Capital is forecasted to decline to about 1.9
B. At present, Eyebright Medical's
Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's
Interest Expense is expected to grow to about 10.3
M, whereas
Tax Provision is forecasted to decline to about 25.8
M.
Eyebright Medical Technology Company Z Score Analysis
Eyebright Medical's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| First Factor | = | 1.2 * ( | Working Capital | / | Total Assets ) |
|
| Second Factor | = | 1.4 * ( | Retained Earnings | / | Total Assets ) |
|
| Thrid Factor | = | 3.3 * ( | EBITAD | / | Total Assets ) |
|
| Fouth Factor | = | 0.6 * ( | Market Value of Equity | / | Total Liabilities ) |
|
| Fifth Factor | = | 0.99 * ( | Revenue | / | Total Assets ) |
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
In accordance with the company's disclosures, Eyebright Medical Technology has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the
Health Care industry. The z score for all China stocks is 100.0% higher than that of the company.
| | Content SyndicationQuickly integrate customizable finance content to your own investment portal |
Eyebright Fundamentals
About Eyebright Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Eyebright Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Eyebright Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Eyebright Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Currently Active Assets on Macroaxis
Other Information on Investing in Eyebright Stock
Eyebright Medical financial ratios help investors to determine whether Eyebright Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eyebright with respect to the benefits of owning Eyebright Medical security.